Global Transcatheter Aortic Valve Implantation (TAVI) Market to Reach US$ 16.1 Billion by 2032, Propelled by Aging Population

September 29, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Transcatheter Aortic Valve Implantation (TAVI) Market by Procedure (Transfemoral Procedure, Transapical Implantation, Transaortic Implantation), End User (Hospitals, Diagnostic Labs, Ambulatory Surgical Centers, Clinics, and Others), and Region 2024-2032, the global transcatheter aortic valve implantation (TAVI) market size reached US$ 6.3 Billion in 2023. Transcatheter aortic valve implantation (TAVI) is a minimally invasive surgical procedure that serves as an alternative to open-heart surgery for treating aortic stenosis. Aortic stenosis is a condition characterized by the narrowing of the aortic valve, restricting blood flow from the heart to the rest of the body. Unlike traditional surgical methods that require opening the chest cavity, TAVI allows for the replacement of the aortic valve via a catheter inserted through a small incision, often in the femoral artery in the leg. The hallmark characteristics of TAVI include its less invasive nature, shorter recovery times, and its suitability for patients who are at high risk for conventional surgical procedures. The procedure usually employs imaging techniques like fluoroscopy or echocardiography for precise valve placement. Features of the TAVI procedure often include the use of a balloon-expandable or self-expanding valve, which is mounted on a catheter and guided into position. Once in the desired location, the new valve is deployed, either by inflating the balloon or through self-expansion, effectively taking over the function of the diseased valve. TAVI’s features include high efficacy, reduced hospitalization durations, and its ability to improve the quality of life for patients who may not be candidates for traditional surgical interventions.

Global Transcatheter Aortic Valve Implantation (TAVI) Market Trends:

The increase in the global aging population represents one of the key factors driving the market growth. Moreover, technological innovations in valve design and implantation techniques are major growth inducing factors. In addition to this, successful clinical trials are bolstering the credibility and acceptance of TAVI as a viable treatment option which, in turn, are driving the growth of the market. The application of data analytics for post-procedure monitoring and feedback has improved success rates, thereby encouraging more clinicians to opt for TAVI. Besides this, the rising awareness among healthcare professionals and the general public is resulting in more referrals for TAVI procedures, which, in turn, is fostering the market growth. Along with this, better healthcare facilities and diagnostic tools help in early and accurate diagnosis, thereby bolstering the market growth. Apart from this, the availability of TAVI procedures in emerging markets is significantly contributing to the market growth. Furthermore, financial incentives and favorable reimbursement policies by governments have made TAVI more accessible, which is creating a positive outlook for the market. Other factors such as increasing competition among manufacturers, swift regulatory approvals for new devices and technologies, and collaboration between hospitals, manufacturers, and governments are driving the growth of the market across the globe. Looking forward, the market value is projected to reach US$ 16.1 Billion by 2032, expanding at a CAGR of 10.65% during 2024-2032.

Market Summary:

  • On the basis of the procedure, the market is segmented into transfemoral procedure, transapical implantation, and transaortic implantation. Currently, transfemoral procedure holds the largest market share.
  • On the basis of the end user, the market is segmented into hospitals, diagnostics labs, ambulatory surgical centers, clinics, and others. At present, hospitals represent the leading end user.
  • Region wise, the market is segmented into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. Presently, North America accounts for the majority of the market share.
  • The competitive landscape of the industry has also been examined, with some of the key players being Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, JC Medical Inc. (Genesis Medtech International Private Limited), Medtronic plc, Meril Life Sciences Pvt. Ltd., NVT AG (Biosensors International Group) and Venus Medtech (Hangzhou) Inc.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Procedures Covered Transfemoral Procedure, Transapical Implantation, Transaortic Implantation
End Users Covered Hospitals, Diagnostic Labs, Ambulatory Surgical Centers, Clinics, Others
Regions Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, JC Medical Inc. (Genesis Medtech International Private Limited), Medtronic plc, Meril Life Sciences Pvt. Ltd., NVT AG (Biosensors International Group), Venus Medtech (Hangzhou) Inc., etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Transcatheter Aortic Valve Implantation (TAVI) Market to Reach US$ 16.1 Billion by 2032, Propelled by Aging Population
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More